HomeALT • NASDAQ
add
Altimmune Inc
Previous close
$7.08
Day range
$6.78 - $7.25
Year range
$2.09 - $14.84
Market cap
510.45M USD
Avg Volume
3.90M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 37.00K | 133.64% |
Operating expense | 4.33M | 13.85% |
Net income | -31.64M | -46.08% |
Net profit margin | -85.52K | -534.29% |
Earnings per share | -0.33 | 25.25% |
EBITDA | -19.31M | 14.66% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 197.82M | 7.00% |
Total assets | 210.64M | 1.79% |
Total liabilities | 16.54M | -23.55% |
Total equity | 194.10M | — |
Shares outstanding | 70.90M | — |
Price to book | 2.57 | — |
Return on assets | -28.11% | — |
Return on capital | -30.65% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -31.64M | -46.08% |
Cash from operations | -16.53M | 4.47% |
Cash from investing | -7.96M | -911.31% |
Cash from financing | 72.75M | 169,295.35% |
Net change in cash | 48.26M | 394.86% |
Free cash flow | -8.26M | 13.71% |
About
Founded
1997
Headquarters
Website
Employees
59